Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Elevate Your Team's Expertise: MTRC Launches Free Market Access Training

MTRC is proud to announce the launch of the MTRC Market Access Training Program. This complimentary initiative is designed to equip professionals who are new to the MedTech field or transitioning from pharmaceuticals with essential market access skills. 

The program provides a comprehensive learning experience, combining self-paced recorded sessions, live webinars for interactive discussion, and a capstone project reviewed with confidential feedback from MTRC's industry experts. The inaugural cohort, commencing 15 January 2026, will concentrate on market access pathways for medical devices in acute and specialist care environments. 

We encourage you to identify and nominate colleagues who are well-positioned to leverage this strategic development opportunity. 

Discover the full program curriculum and enrollment details here.